Retinol binding protein and transthyretin modulators for treating hypertosis, Alzheimer's disease or idiopathic intracranial hypertension
    4.
    发明公开
    Retinol binding protein and transthyretin modulators for treating hypertosis, Alzheimer's disease or idiopathic intracranial hypertension 审中-公开
    视黄醇结合蛋白与蛋白 - 蛋白 - 丝氨酸蛋白 - 调节素Zur Behandlung von升血,Morbus阿尔茨海默病痴呆症颅内高血压

    公开(公告)号:EP2289500A1

    公开(公告)日:2011-03-02

    申请号:EP10181763.3

    申请日:2005-12-07

    IPC分类号: A61K31/165 A61P9/00 A61P25/28

    摘要: Described herein are methods and compositions for treating certain retinol-related diseases and conditions by modulation of transthyretin (TTR) and retinol binding protein (RBP) availability in the subject. For example, the methods and compositions provide for therapeutic agents for the treatment and/or prevention of age-related macular degeneration and/or dystrophies, metabolic disorders, idiopathic intracranial hypertension, hyperostosis, and protein misfolding and aggregation diseases. The compositions disclosed may be used as single agent therapy or in combination with other agents or therapies. In addition, described herein are methods and assays for selecting appropriate agents that can modulate the TTR and RBP availability in a subject.

    摘要翻译: 本文描述了通过调节受试者中转甲状腺素蛋白(TTR)和视黄醇结合蛋白(RBP)可用性来治疗某些视黄醇相关疾病和病症的方法和组合物。 例如,所述方法和组合物提供用于治疗和/或预防年龄相关性黄斑变性和/或营养不良,代谢紊乱,特发性颅内高血压,骨质增生和蛋白质错误折叠和聚集疾病的治疗剂。 所公开的组合物可以用作单一药物治疗或与其它药物或疗法组合使用。 此外,本文描述了用于选择可以调节受试者的TTR和RBP可用性的适当试剂的方法和测定。